Pacific Biomarkers

SEATTLE, WA -- (Marketwire) -- 12/29/11 -- Pacific Biomarkers (PBI), a Seattle, WA-based limited liability company that provides premier biomarker and specialty efficacy testing services to the drug development industry, has named the company's current Vice President, Research and Development, Amar A. Sethi, MD, PhD, as the new ... read more

SEATTLE, WA -- (Marketwire) -- 12/21/11 -- Pacific Biomarkers (PBI), a Seattle, WA-based limited liability company that provides premier biomarker and specialty efficacy testing services to the drug development industry, and Clinigene International Limited, an India-based CRO that offers end-to-end clinical and laboratory services for accelerating clinical research, ... read more

SEATTLE, WA -- (Marketwire) -- 09/24/10 -- Pacific Biomarkers, Inc. (OTCBB: PBMC), which provides specialty laboratory services to support pharmaceutical, biotechnology and laboratory diagnostic companies in the conduct of human clinical research, for use in their drug and diagnostic product development efforts, today released its financial results for FY2010. For the twelve months ended ... read more

SEATTLE, WA -- (Marketwire) -- 07/22/10 -- Dr. Amar Sethi, VP of Science and Technology at Pacific Biomarkers, Inc. (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology, and diagnostics industries, is the lead author of a research study published in the July issue of ... read more